Skip to main content

Table 1 Characteristics of the observational studies

From: Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies

Study (design)

Country

Sample size (male %); Population

BMD assessment techniques (anatomical sites)

Bone biomarkers

PA assessment method

Results BMD

Results Bone biomarkers

Dolgos et al. 2008 [20] (Cross-sectional)

Norway

n = 108 (68%) Kidney Transplant

DXA – Lunar (LS, proximal femur both sides, and total body)

iPTH

Self-report questionnaire

Physical active vs. physical

Inactive (defined as regular weight-bearing physical exercise performed at least twice a week for 30 min)

Association with total body BMD

No association with LS and proximal femur BMD

No association with iPTH

Huang et al. 2009 [22] (Cross-sectional)

Taiwan

n = 35 HD

DXA – Hologic (LS and FN)

iPTH

ALP

Self-report interview questionnaire

Total weekly exercise time (min/week): regular exercise (yes or no), exercise type (impact or non-impact) and effective exercise time (min/week)

Positive association with all BMD outcomes

No association with all bone biomarkers

Morishita et al. 2014 [24] (Cross-sectional)

Japan

n = 32 (56%) HD

BALP

iP1NP

TRAP-5b

iPTH

Device- Triaxial pedometer

Vigorous and moderate PA volumes per week

No association with all bone biomarkers

Ota et al. 1997 [25] (Cross-sectional)

Japan

n = 32 (0%) HD

DXA – Lunar (Total body and LS)

iPTH

OC

ALP

TRAP-5b

Device – Accelerometer

Total energy expenditure per day (Kcal) for 7 days - mean energy expenditure per day

Positive association with total body BMD

No association with LS BMD

No association with all bone biomarkers

Groth et al. 1995 [21] (Longitudinal - 2-year follow-up)

Germany

n = 115 (61%) Kidney Transplant

DXA- Lunar (LS)

ALP

iPTH

OC

Self-report questionnaire

Estimated energy spending during sports

Positive association with bone gain (r = 0.2, p < 0.05)

No association with all bone biomarkers

Malluche et al. 2017 [23] (Longitudinal - 1-year follow-up)

USA

n = 45 HD

DXA - Lunar and QCT (LS and proximal femur)

TRAP-5b; BALP

P1NP; Sclerostin

DKK1; FGF-23

iPTH

Self-report questionnaire Exercised 1+ days/week

No association with bone loss

No association with all bone biomarkers

  1. ALP Alkaline Phosphatase, BALP Bone-specific Alkaline Phosphatase, BMD Bone Mineral Density, DKK1 Dickkopf-related protein 1, DXA Dual-energy X-ray absorptiometry, FGF-23 Fibroblast Growth Factor 23, FN Femoral Neck, HD Haemodialysis, iPTH Intact Parathyroid Hormone, LS Lumbar Spine, OC Osteocalcin, PA Physical Activity, P1NP Procollagen type I N-terminal Propeptide, TRAP-5b Tartrate-resistant acid phosphatase 5b